CA2 - carbonic anhydrase 2 Gene

Homo sapiens

Also known as CAC; CAII; Car2; CA-II; HEL-76; HEL-S-282

Gene ID: 760 | Gene type: protein coding

About CA2

Cytogenetic location: 8q21.2 Genomic coordinates (GRCh38): 8:85,464,007-85,481,493 (from NCBI)

This gene has 5 transcripts (splice variants), 285 orthologues, 14 paralogues and is associated with 3 phenotypes. Biased expression in stomach (RPKM 493.8), colon (RPKM 349.1) and 8 other tissues.

Summary

The protein encoded by this gene is one of several isozymes of Carbonic Anhydrase, which catalyzes reversible hydration of carbon dioxide. Defects in this Enzyme are associated with osteopetrosis and renal tubular acidosis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

CA2 Products(2)

mRNA	Protein	Name
NM_001293675.2	NP_001280604.1	carbonic anhydrase 2 isoform 2
NM_000067.3	NP_000058.1	carbonic anhydrase 2 isoform 1

CA2 Protein Structure

Carb_anhydrase

0
100
200
260 a.a.

Protein Preferred Names

Protein Names

carbonic anhydrase 2

carbonate dehydratase II	carbonic anhydrase B
carbonic anhydrase C	carbonic anhydrase II
carbonic dehydratase	cyanamide hydratase CA2
epididymis luminal protein 76	epididymis secretory protein Li 282

Recombinant CA2 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P72860	Carbonic Anhydrase 2 Protein, Human (C-His, Solution)	NP_000058.1 (S2-K260)	≥95%
HY-P78746	Carbonic Anhydrase 2 Protein, Human (HEK293, His)	NP_000058.1 (M1-K260)	≥95%

Related Diseases

Diseases

Alias

Distal Renal Tubular Acidosis

Classic Rta	Familial Distal Primary Acidosis
Renal Tubular Acidosis Type 1	Drta
Renal Tubular Acidosis, Distal

Osteopetrosis, Autosomal Recessive 3

Osteopetrosis With Renal Tubular Acidosis	Marble Brain Disease
OPTB3	Guibaud-Vainsel Syndrome
Carbonic Anhydrase Ii Deficiency	Osteopetrosis, Autosomal Recessive 3, With Renal Tubular Acidosis
Autosomal Recessive Osteopetrosis 3	Carbonic Anhydrase 2 Deficiency
Autosomal Recessive Osteopetrosis 3 With Renal Tubular Acidosis	Osteopetrosis Autosomal Recessive 3
Autosomal Recessive Osteopetrosis Type 3	Guibaud Vainsel Syndrome
Mixed Rta	Mixed Renal Tubular Acidosis
Renal Tubular Acidosis Type 3	Carbonic Anhydrase Ii Deficiency Syndrome
Carbonic Anhydrase Ii Variant	Osteopetrosis, Autosomal Recessive, Type 3
Carbonic Anhydrase 2

Autoimmune Hepatitis

Aih	Hepatitis, Autoimmune
Autoimmune Chronic Active Hepatitis	Autoimmune Hepatitis With Centrilobular Necrosis
Autoimmune Chronic Hepatitis	Hepatitis Autoimmune

Corneal Dystrophy, Band-Shaped

Band Keratopathy

Band-Shaped Keratopathy

Primary Biliary Cholangitis

Primary Biliary Cirrhosis	Biliary Liver Cirrhosis
Chronic Nonsuppurative Destructive Cholangitis	Familial Primary Biliary Cirrhosis
Pbc	Hanot Syndrome
Cholestatic Cirrhosis	Biliary Cirrhosis Primary
Liver Cirrhosis, Biliary	Hanot'S Cirrhosis
Biliary Cirrhosis	Pericholangiolic Biliary Cirrhosis
Tannhauser-Magendantz Syndrome	Hanot-Rossle Syndrome
Hypertrophic Cirrhosis	Todd Cirrhosis
Hanot Cirrhosis	Charcot Cirrhosis
Mahon-Tannhauser Syndrome	Toxic Cirrhosis
Hypertrophic Biliary Cirrhosis	Monolobular Cirrhosis
Unilobar Cirrhosis	Xanthomatous Biliary Cirrhosis

Pancreatitis

Mumps Pancreatitis

Sjogren Syndrome

Sicca Syndrome	Sjogren'S Syndrome
Sjogren-Gougerot Syndrome	Sjögren Syndrome
Keratoconjunctivitis Sicca	Sjögren'S Syndrome
Xerodermosteosis	Dacryosialoadenopathia Atrophicans
Gougerot-Houwer-Sjogren Syndrome	Gougerot-Sjogren Syndrome
Keratoconjunctivitis Sicca-Xerostomia	Secreto-Inhibitor-Xerodermostenosis
Primary Sjogren Syndrome	Primary Sjogren-Gougerot Syndrome
Sjogrens Syndrome Primary	Sjogrens Syndrome
Dry Eye Syndromes

Cholangitis

Acute Cholangiolitis	Ascending Cholangitis
Cholangiolitis	Cholangitis Nos
Chronic Cholangiolitis	Hepatic Duct Inflammation
Acute Cholangitis	Bile Duct Inflammation

Multiple Cranial Nerve Palsy

Multiple Cranial Nerve Palsies

Benign Giant Cell Tumor

Giant Cell Tumors

Eye Disease

Eye Diseases	Abnormality Of The Eye
Toxoplasma Oculopathy

Osteopetrosis, Autosomal Dominant 2

OPTA2	Autosomal Dominant Osteopetrosis 2
Osteopetrosis Autosomal Dominant Type 2	Osteopetrosis, Autosomal Dominant, Type Ii
Albers-Schonberg Osteopetrosis	Autosomal Dominant Albers-Schonberg Disease
Osteopetrosis	Marble Bones, Autosomal Dominant
Osteosclerosis Fragilis Generalisata	Albers-Schonberg Disease, Autosomal Dominant
Autosomal Dominant Osteopetrosis Type Ii	Albers-Schönberg Osteopetrosis
Autosomal Dominant Osteopetrosis Type 2	Marble Disease Autosomal Dominant
Osteopetrosis, Autosomal Dominant, Type 2

Deficiency Anemia

Anemia	Deficiency Anemias
Anaemia

Glossopharyngeal Nerve Disease

Ninth Cranial Nerve Disease	Glossopharyngeal Nerve Diseases
Disorders Of The Ninth Cranial Nerve	Disorders Of 9th Cranial Nerve

Pancreatic Cancer

Pancreatic Carcinoma	Familial Pancreatic Carcinoma
Pancreatic Neoplasm	Carcinoma Of Pancreas
Pancreatic Carcinoma, Familial	Malignant Neoplasm Of Pancreas
Pancreatic Acinar Carcinoma	Pancreatic Tumor
Familial Pancreatic Cancer	Neoplasm Of The Pancreas
Pancreatic Carcinoma, Somatic	Pancreatic Cancer, Somatic
Ca Body Of Pancreas	Ca Head Of Pancreas
Ca Tail Of Pancreas	Malignant Neoplasm Of Body Of Pancreas
Malignant Neoplasm Of Head Of Pancreas	Malignant Neoplasm Of Tail Of Pancreas
Pancreas Neoplasm	Exocrine Cancer
Exocrine Pancreas Carcinoma	Hereditary Pancreatic Cancer
Hereditary Pancreatic Carcinoma	PNCA
Cancer Of The Pancreas	Pancreatic Cancer, Susceptibility To
Carcinoma Of Head Of Pancreas	Pancreatic Neoplasms
Pancreatic Tumors	Cancer, Pancreatic
Cancer Of Pancreas	Mixed Islet Cell With Exocrine Carcinoma Of Unspecified Site

Endosteal Hyperostosis, Autosomal Dominant

Osteosclerosis	Worth Syndrome
Osteosclerosis, Autosomal Dominant	Hyperostosis, Endosteal
Endosteal Hyperostosis, Worth Type	Worth Disease
Autosomal Dominant Osteosclerosis, Worth Type	Hyperostosis Corticalis Generalisata, Benign Form Of Worth, With Torus Palatinus
Autosomal Dominant Endosteal Hyperostosis	Autosomal Dominant Osteosclerosis
Benign Form Of Worth Hyperostosis Corticalis Generalisata With Torus Platinus	Worth'S Syndrome
Worth Type Autosomal Dominant Osteosclerosis	Hyperostosis Corticalis Generalisata, Benign Form Of Worth With Torus Palatinus
Osteosclerosis, Autosomal Dominant, Worth Type	WENHY
Endosteal Hyperostosis Autosomal Dominant	Hyperostosis Corticalis Generalisata Benign Form Of Worth With Torus Palatinus
Osteosclerosis Autosomal Dominant	Acquired Osteosclerosis

Retinitis Pigmentosa

RP	Rod-Cone Dystrophy
Autosomal Recessive Retinitis Pigmentosa	Non-Syndromic Retinitis Pigmentosa
Pericentral Pigmentary Retinopathy	Pigmentary Retinopathy
Tapetoretinal Degeneration	Rcd
Retinitis Pigmentosa Autosomal Recessive	ARRP
Retinitis Pigmentosa, Autosomal Recessive	Retinitis Pigmentosa 1

Intracranial Hypertension, Idiopathic

Pseudotumor Cerebri	Benign Intracranial Hypertension
Idiopathic Intracranial Hypertension	Iih
Benign Intracran. Hypt.

Hereditary Elliptocytosis

Congenital Elliptocytosis	Ovalocytosis
Elliptocytosis, Hereditary	He
Elliptocytosis Hereditary	Congenital Ovalocytosis
Elliptocytosis	Hereditary Elliptocytosis With Infantile Poikilocytosis
Hereditary Ovalocytosis	Oval Erythrocytosis
He - [Hereditary Elliptocytosis]	Elliptocytosis Anaemia

Ocular Hypertension

Hypertension, Ocular	Intraocular Pressure Increase
Oh - [Ocular Hypertension]	Oht - [Ocular Hypertension]

Intraocular Pressure Quantitative Trait Locus

Glaucoma	IOPQTL
Glaucoma, Susceptibility To	Postinfectious Glaucoma
Glaucoma With Ocular Inflammation	Glaucoma Secondary To Eye Inflammation
Traumatic Glaucoma	Glaucoma With Concussion Of Globe
Glaucoma Due To Ocular Trauma	Glaucoma Associated With Ocular Trauma
Glaucoma Secondary To Drugs

Igg4-Related Disease

Multifocal Fibrosclerosis	Igg4-Related Sclerosing Disease
Igg4-Related Systemic Disease	Immunoglobulin G4-Related Sclerosing Disease
Hyper-Igg4 Disease	Igg4-Associated Disease
Igg4-Positive Multiorgan Lymphoproliferative Syndrome	Igg4-Related Autoimmune Disease
Igg4-Related Systemic Sclerosing Disease	Igg4-Syndrome
Multifocal Idiopathic Fibrosclerosis	Systemic Igg4-Related Plasmacytic Syndrome
Systemic Igg4-Related Sclerosing Syndrome	Mediastinal Fibrosis, Familial
Retroperitoneal Fibrosis, Familial	Igg4-Rd

Osteoporosis

Postmenopausal Osteoporosis	Osteoporosis, Postmenopausal
Bone Mineral Density Quantitative Trait Locus	Bmnd
Osteoporosis, Involutional	Osteoporosis, Susceptibility To
Osteoporosis, Postmenopausal, Susceptibility	Bone Mineral Density Variation Qtl, Osteoporosis
OSTEOP	Involutional Osteoporosis
Senile Osteoporosis	Osteoporosis Postmenopausal
Bone Mineral Density, Quantitative Trait Locus	Osteoporosis, Senile
Idiopathic Osteoporosis	Bone Rarefaction Nos
Type 1 Osteoporosis

Cone-Rod Dystrophy 2

Cone-Rod Dystrophy	CORD2
Cone-Rod Retinal Dystrophy	Rcrd2
Cone-Rod Retinal Dystrophy 2	Crd2
Cord	Crd
Retinal Cone-Rod Dystrophy	Cone-Rod Retinal Dystrophy-2
Retinal Cone-Rod Dystrophy 2	Tapetoretinal Degeneration
Cone-Rod Degeneration	Cone Rod Dystrophy
Dystrophy, Cone-Rod	Dystrophy, Cone-Rod, Type 2
Retinitis Pigmentosa	Retinitis Pigmentosa 2
Progressive Cone-Rod Dystrophy

Renal Tubular Transport Disease

Renal Tubular Transport, Inborn Errors

Inborn Renal Tubular Transport Disorder

Autoimmune Pancreatitis

Lymphoplasmocytic Sclerosing Pancreatitis

Aip

Mikulicz Disease

Igg4-Related Dacryoadenitis And Sialadenitis	Mikulicz'S Disease
Chronic Dacryoadenitis And Sialadenitis	Mikulicz Syndrome
Mikulicz' Disease

Autoimmune Cholangitis

Autoimmune Cholangiopathy

Renal Tubular Acidosis

Acidosis Renal Tubular	Acidosis, Renal Tubular
Lightwood-Albright Syndrome	Lightwood Syndrome
Idiopathic Infantile Hypercalcemia - Mild Form	Kidney Tubular Acidosis
Renal Tubule Acidosis	Kidney Acidosis
Renal Acidosis	Renal Hyperchloremic Acidosis
Rta - [Renal Tubular Acidosis]

Nephrocalcinosis

Hypercalcemic Nephropathy

Subacute Lymphocytic Thyroiditis

Osteopetrosis

Albers-Schonberg Disease	Marble Bone Disease
Osteopetroses	Marble Bones
Osteopetrosis And Related Disorders	Congenital Osteopetrosis
Marble Bone	Albers-Schoenberg Disease
Albers-Schonberg Osteopetrosis	Osteosclerosis Fragilis
Ivory Bones

Breast Cancer

Breast Carcinoma	Breast Cancer, Familial
Malignant Neoplasm Of Breast	Male Breast Cancer
Breast Cancer, Susceptibility To	Breast Cancer, Early-Onset
Malignant Tumor Of Breast	Carcinoma Of Male Breast
Breast Cancer, Invasive Ductal	Breast Cancer, Protection Against
Breast Cancer, Somatic	Breast Cancer, Male
Breast Cancer, Lobular, Somatic	Breast Tumor
Mammary Cancer	Mammary Tumor
Malignant Neoplasm Of Male Breast	Mammary Carcinoma
Male Breast Carcinoma	Familial Cancer Of Breast
Invasive Ductal Breast Carcinoma	Breast Cancer Susceptibility
Breast Cancer, Male, Susceptibility To	Breast Cancer, Early-Onset, Susceptibility To
Malignant Tumor Of The Breast	Mammary Neoplasm
Primary Breast Cancer	Neoplasm Of Male Breast
Carcinoma Of Breast	Breast Cancer In Men
Familial Breast Cancer	Cancer Of Breast
BC	Breast Cancer Familial
Breast Cancer Familial Male	Breast Cancer, Familial Male
Breast Male Carcinoma	Breast Neoplasms
Breast Neoplasms, Male	Mammary Tumors
Mammary Carcinomas	Cancer, Breast
Cancer, Breast, Susceptibility	Invasive Breast Ductal Carcinoma
Breast Neoplasm	Susceptibility To Breast Cancer
Mammary Neoplasms	Animal Mammary Neoplasms
Primary Malignant Neoplasm Of Breast	Infiltrating Ductal Carcinoma Of Breast
Infiltrating Duct Carcinoma Of Unspecified Site	Infiltrating Ductular Carcinoma Of Unspecified Site
Invasive Breast Carcinoma Of No Special Type	Microinvasive Carcinoma Of Breast
Carcinoma With Apocrine Differentiation

Metabolic Acidosis

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval

Bioactive Molecules (43)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10341	Fasudil Hydrochloride		99.96%	Yes
HY-13764	Tetrandrine	Inhibitor	99.91%	Yes
HY-B0246	Carbamazepine		99.93%	Yes
HY-A0057	Gabapentin	Inhibitor	≥98.0%	Yes
HY-B1193	Terfenadine		99.91%	Unkown
HY-75161	(-)-Menthol	Activator	≥98.0%	Unkown
HY-14656	Diltiazem hydrochloride	Antagonist	99.04%	Yes
HY-12542	Dantrolene		≥98.0%	Yes
HY-B1221	Flufenamic acid		99.85%	Unkown
HY-15553A	Mibefradil dihydrochloride	Inhibitor	≥98.0%	Yes
HY-N1370	Tanshinone IIA sulfonate sodium	Inhibitor	98.83%	Unkown
HY-B0358A	Flunarizine dihydrochloride		99.87%	Yes
HY-B1546A	Benzamil hydrochloride	Inhibitor	99.80%	Unkown
HY-B1077	Penfluridol		99.93%	Unkown
HY-17404	Cilnidipine	Inhibitor	99.92%	Yes
HY-B0596	Taltirelin	Agonist	99.86%	Unkown
HY-12542A	Dantrolene sodium hemiheptahydrate	Inhibitor	99.79%	Yes
HY-B1424	Benzthiazide		99.70%	Unkown
HY-A0082	Diphenidol hydrochloride	Antagonist	99.95%	Unkown
HY-B1671	(+)-Kavain		99.98%	Unkown
HY-75839	Dronedarone Hydrochloride		99.93%	Unkown
HY-103370	Talniflumate	Inhibitor	99.67%	Yes
HY-B0632	Diltiazem	Inhibitor	99.49%	Yes
HY-A0057A	Gabapentin hydrochloride	Inhibitor	≥98.0%	Yes
HY-121186	Bevantolol hydrochloride	Antagonist	98.98%	Yes
HY-14657	Dantrolene sodium	Inhibitor	≥98.0%	Yes
HY-16952A	Bepridil hydrochloride hydrate		99.73%	Unkown
HY-107319	Almitrine mesylate	Inhibitor	99.81%	Unkown
HY-U00212	Aranidipine	Antagonist	98.67%	Unkown
HY-P1769	Angiotensin II (5-8), human		99.68%	Unkown
HY-B0596A	Taltirelin acetate	Agonist	98.77%	Unkown
HY-10341A	Fasudil		/	Unkown
HY-10341B	Fasudil hydrochloride semihydrate		/	Unkown
HY-10341C	Fasudil dihydrochloride		/	Unkown
HY-109545	Isopropyl unoprostone	Activator	/	Unkown
HY-14656R	Diltiazem hydrochloride (Standard)	Antagonist	/	Unkown
HY-75839R	Dronedarone Hydrochloride (Standard)		/	Unkown
HY-A0270	Diphenidol	Antagonist	/	Unkown
HY-B0401A	Tolbutamide sodium	Inducer	/	Unkown
HY-B1558	Bifemelane		/	Unkown
HY-P1792	Angiotensin II (1-4), human	Agonist	/	Unkown
HY-P1792A	Angiotensin II (1-4), human TFA	Agonist	/	Unkown
HY-B1546	Benzamil		/	Unkown

Clinical Phase

Bioactive Molecules (24)

Cat. No.	Product Name	Effect	Purity	Phase
HY-N6687	Calcimycin		99.12%	Phase 4
HY-100560	Abscisic acid	Inhibitor	99.72%	Phase 4
HY-B0358	Flunarizine		99.87%	Phase 4
HY-N6687A	Calcimycin hemicalcium salt		/	Phase 4
HY-N6687B	Calcimycin hemimagnesium		/	Phase 4
HY-50694	Senicapoc	Inhibitor	99.88%	Phase 3
HY-10805	Almorexant		99.71%	Phase 3
HY-10805A	Almorexant hydrochloride		99.98%	Phase 3
HY-N1584	Halofuginone		99.92%	Phase 2
HY-N1584A	Halofuginone hydrobromide		99.99%	Phase 2
HY-15724	Vercirnon	Antagonist	98.26%	Phase 2
HY-100779	Rimacalib		99.65%	Phase 2
HY-19721	ABT-639	Inhibitor	99.32%	Phase 2
HY-15293B	JTV-519 hemifumarate	Inhibitor	98.69%	Phase 2
HY-147301	Resomelagon	Agonist	99.63%	Phase 2
HY-100298	Caldaret	Inhibitor	98.35%	Phase 2
HY-15293A	JTV-519 free base		/	Phase 2
HY-100973A	Adenosine 5′-diphosphoribose sodium		99.03%	Phase 1
HY-129851	NTP42	Antagonist	98.02%	Phase 1
HY-120588	BI 639667	Antagonist	99.47%	Phase 1
HY-16935	Mavatrep	Antagonist	99.60%	Phase 1
HY-115681	(2R/S)-6-PNG	Inhibitor	99.88%	Phase 1
HY-133011	nAChR agonist 1	Agonist	98.35%	Phase 1
HY-15553	Mibefradil	Inhibitor	/	Phase 1

Pre-clinical Phase

Bioactive Molecules (431)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-13433	Thapsigargin		99.95%	Unkown
HY-18723	Yoda 1		99.98%	Unkown
HY-100545	BAPTA-AM	Inhibitor	99.68%	Unkown
HY-W009724	2-Aminoethyl diphenylborinate		98.36%	Unkown
HY-D0861	EGTA		≥98.0%	Unkown
HY-101896	Fluo-4 AM		≥99.0%	Unkown
HY-108496	Sphingosine-1-phosphate	Agonist	≥98.0%	Unkown
HY-19608	GSK1016790A		99.79%	Unkown
HY-N0219	Bicuculline	Antagonist	99.97%	Unkown
HY-100202	TPEN		99.69%	Unkown
HY-100168	BAPTA	Inhibitor	≥98.0%	Unkown
HY-126010	Dooku1	Antagonist	99.89%	Unkown
HY-10588	Bay K 8644	Agonist	98.62%	Unkown
HY-100831	YM-58483	Inhibitor	99.78%	Unkown
HY-P2149	Concanavalin A	Inducer	/	Unkown
HY-12323	ISX-9	Activator	98.90%	Unkown
HY-118630	Vacuolin-1	Inhibitor	98.93%	Unkown
HY-D0989	Rhod-2 AM		≥97.0%	Unkown
HY-101455	CDN1163	Activator	99.86%	Unkown
HY-131614	TPC2-A1-N	Inhibitor	99.86%	Unkown
HY-120691A	GSK205	Antagonist	99.91%	Unkown
HY-N6732	K-252a		99.45%	Unkown
HY-100001	SKF-96365 hydrochloride		99.91%	Unkown
HY-15754	CGP37157	Inhibitor	99.50%	Unkown
HY-10007	NPS-2143	Antagonist	99.33%	Unkown
HY-113308A	Taurolithocholic acid sodium salt	Agonist	98.02%	Unkown
HY-138620	MCU-i4	Inhibitor	99.87%	Unkown
HY-103319	Calmidazolium chloride	Antagonist	99.69%	Unkown
HY-100912	W-7 hydrochloride		99.65%	Unkown
HY-101379A	8-Bromo-cGMP sodium	Inhibitor	99.07%	Unkown
HY-15415	KB-R7943 mesylate	Inhibitor	99.16%	Unkown
HY-108465	Pyr3	Inhibitor	99.90%	Unkown
HY-103312	Xestospongin C	Inhibitor	≥90.0%	Unkown
HY-119287	TSQ		99.88%	Unkown
HY-108599	DCP-LA		≥98.0%	Unkown
HY-123071A	Box5 TFA	Antagonist	94.71%	Unkown
HY-101906	DC260126		99.74%	Unkown
HY-P0256	Apamin	Inhibitor	99.85%	Unkown
HY-12949	ML204	Inhibitor	99.08%	Unkown
HY-15124	(S)-(-)-Bay-K-8644	Agonist	98.81%	Unkown
HY-116330A	Hyperforin dicyclohexylammonium salt		99.52%	Unkown
HY-116429	Maresin 1	Inhibitor	≥99.0%	Unkown
HY-N0043	Ginsenoside Rd	Inhibitor	98.07%	Unkown
HY-15515	SEA0400	Inhibitor	99.96%	Unkown
HY-D0973	EGTA-AM		≥90.0%	Unkown
HY-N6789	KT5720	Inhibitor	≥99.0%	Unkown
HY-19805	STO-609	Inhibitor	98.13%	Unkown
HY-119401	CAY10444	Antagonist	≥98.0%	Unkown
HY-N6778	Paxilline	Inhibitor	99.57%	Unkown
HY-101044	PPADS tetrasodium		≥95.0%	Unkown
HY-D1024	Coelenterazine h		98.02%	Unkown
HY-110105	NS8593 hydrochloride	Inhibitor	99.81%	Unkown
HY-120261	GB-88	Inhibitor	99.05%	Unkown
HY-D0716	Fluo-3AM		≥99.0%	Unkown
HY-19408	Pyr10	Inhibitor	99.42%	Unkown
HY-14229	TGR5 Receptor Agonist	Agonist	99.86%	Unkown
HY-120528A	GB-110 hydrochloride	Agonist	99.83%	Unkown
HY-12496	NS-1619		≥98.0%	Unkown
HY-16697	CID 16020046	Antagonist	99.87%	Unkown
HY-107543	8-CPT-2Me-cAMP sodium	Activator	99.58%	Unkown
HY-N0252	Catharanthine	Inhibitor	99.53%	Unkown
HY-107411	Bromoenol lactone	Inhibitor	98.41%	Unkown
HY-P3278A	Caloxin 2A1 TFA	Inhibitor	99.96%	Unkown
HY-10171	NPS-2143 hydrochloride	Antagonist	99.80%	Unkown
HY-135897	Urolithin C	Activator	99.66%	Unkown
HY-D1498	Mag-Fluo-4 AM		≥96.0%	Unkown
HY-126750	GNF362	Inhibitor	99.63%	Unkown
HY-103306	Ryanodine		99.30%	Unkown
HY-111208	CCT129957	Inhibitor	98.62%	Unkown
HY-N0515	Ophiopogonin D		99.54%	Unkown
HY-103320A	Calhex 231 hydrochloride	Inhibitor	98.08%	Unkown
HY-10167A	Tecalcet Hydrochloride	Modulator	99.74%	Unkown
HY-N6771	Cyclopiazonic acid	Inhibitor	≥99.0%	Unkown
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	Unkown
HY-W018035	DL-Glyceric Acid		≥97.0%	Unkown
HY-133168	Englerin A	Activator	99.50%	Unkown
HY-P0256A	Apamin TFA	Inhibitor	96.44%	Unkown
HY-15416	NS309	Activator	99.19%	Unkown
HY-107658	SN 6	Inhibitor	99.79%	Unkown
HY-124171	Zinquin ethyl ester		≥99.0%	Unkown
HY-14350	AC-55541	Agonist	99.25%	Unkown
HY-103309	ML218	Inhibitor	99.49%	Unkown
HY-103307	FPL64176	Agonist	99.81%	Unkown
HY-101017	Palmitoylcarnitine chloride		≥98.0%	Unkown
HY-110153	NS19504	Activator	99.93%	Unkown
HY-16992A	W-54011		≥98.0%	Unkown
HY-114252	Strophanthidin	Inhibitor	92.66%	Unkown
HY-N0084	Betulinaldehyde	Inhibitor	98.72%	Unkown
HY-N2344	Procyanidin A1	Inhibitor	99.19%	Unkown
HY-13103	NS 11021		99.23%	Unkown
HY-101897	Fura-2 AM		≥99.0%	Unkown
HY-123205	Oxatomide		99.56%	Yes
HY-124416	ML604086	Inhibitor	99.80%	Unkown
HY-114400	TRPV4 agonist-1 free base	Agonist	99.58%	Unkown
HY-16689	VU 0240551	Inhibitor	99.97%	Unkown
HY-N0601	Ginsenoside Rf	Inhibitor	99.48%	Unkown
HY-Y0413	Biacetyl monoxime		≥98.0%	Unkown
HY-103474	Bicuculline methiodide	Inhibitor	99.24%	Unkown
HY-10388	TTA-Q6	Antagonist	99.97%	Unkown
HY-124873	SERCA2a activator 1	Activator	99.54%	Unkown
HY-101360	1-EBIO	Agonist	99.96%	Unkown
HY-145542	Isovalerylcarnitine chloride	Activator	≥98.0%	Unkown
HY-N4104	Agaric acid	Activator	99.57%	Unkown
HY-P1821A	Myelin Basic Protein TFA		98.37%	Unkown
HY-12504	Pyr6	Inhibitor	98.47%	Unkown
HY-N0607	Ginsenoside Ro		98.69%	Unkown
HY-100168A	BAPTA tetrasodium	Inhibitor	≥95.0%	Unkown
HY-101396	ICA-069673	Activator	99.65%	Unkown
HY-108593	BMS-191011	Activator	98.83%	Unkown
HY-15671	GKA50	Activator	99.57%	Unkown
HY-P0188A	ω-Conotoxin MVIIC TFA	Inhibitor	99.88%	Unkown
HY-P1366	des-Gln14-Ghrelin		98.61%	Unkown
HY-P1845A	PACAP-38 (31-38), human, mouse, rat TFA	Inducer	99.59%	Unkown
HY-16690	BTS	Inhibitor	99.74%	Unkown
HY-137175	TMBIM6 antagonist-1	Antagonist	99.60%	Unkown
HY-101015A	OBAA		99.27%	Unkown
HY-108607	PACOCF3	Inhibitor	≥98.0%	Unkown
HY-135746	OR-1896		99.03%	Unkown
HY-N3945	Glaucine		99.57%	Unkown
HY-P0189A	ω-Conotoxin GVIA TFA	Inhibitor	99.33%	Unkown
HY-16639	ML314	Agonist	99.82%	Unkown
HY-115864	Osavampator	Activator	99.89%	Unkown
HY-136190	TRPC6-PAM-C20	Agonist	99.90%	Unkown
HY-D1903	Fura Red AM		≥91.0%	Unkown
HY-N7063	Nerol		≥97.0%	Unkown
HY-P1250	RFRP-3(human)	Agonist	99.21%	Unkown
HY-P1845	PACAP-38 (31-38), human, mouse, rat	Inducer	99.25%	Unkown
HY-W001538	S-Propargylcysteine		≥97.0%	Unkown
HY-101693A	Senazodan hydrochloride	Inhibitor	99.74%	Unkown
HY-129440	N-(p-Coumaroyl) Serotonin	Inhibitor	99.03%	Unkown
HY-136909	SR33805	Antagonist	99.19%	Unkown
HY-N0385	Gomisin J	Activator	99.84%	Unkown
HY-P1077A	CALP1 TFA		98.30%	Unkown
HY-P1080A	ω-Agatoxin IVA TFA	Inhibitor	96.35%	Unkown
HY-157131	TRPV2-selective blocker 1	Inhibitor	99.84%	Unkown
HY-160187	AAA		≥98.0%	Unkown
HY-101329	Anthracene-9-carboxylic acid		99.09%	Unkown
HY-100168B	BAPTA tetrapotassium	Inhibitor	99.45%	Unkown
HY-108608	o-3M3FBS		99.91%	Unkown
HY-135891	AZD2423	Antagonist	99.46%	Unkown
HY-136460	Calcium ionophore I		≥99.0%	Unkown
HY-P0190A	Iberiotoxin TFA	Inhibitor	99.67%	Unkown
HY-100783	(-)-Bicuculline methobromide		≥99.0%	Unkown
HY-N1940	β-Anhydroicaritin		99.09%	Unkown
HY-P0190	Iberiotoxin		≥98.0%	Unkown
HY-12498	GV-58	Agonist	99.51%	Unkown
HY-103316A	Ned 19	Inhibitor	99.92%	Unkown
HY-103660	18:0 LYSO-PE		≥99.0%	Unkown
HY-107855S	DL-Mevalonolactone-d7		≥99.0%	Unkown
HY-108464A	Phenamil methanesulfonate	Inhibitor	≥98.0%	Unkown
HY-120597	SAK3	Activator	≥99.0%	Unkown
HY-125703	Ferutinin		≥99.0%	Unkown
HY-128678	ORM-10103	Inhibitor	99.97%	Unkown
HY-D0202	Arsenazo III		≥95.0%	Unkown
HY-P1076A	CALP2 TFA	Antagonist	98.48%	Unkown
HY-P1247	Calcineurin autoinhibitory peptide	Inhibitor	99.96%	Unkown
HY-P1479A	Calmodulin-Dependent Protein Kinase II(290-309) acetate		98.45%	Unkown
HY-41076	Ca2+ channel agonist 1		99.71%	Unkown
HY-10066	Nelivaptan	Antagonist	98.35%	Unkown
HY-101366	A-61603	Agonist	≥98.0%	Unkown
HY-136182A	YM-244769	Inhibitor	98.04%	Unkown
HY-145384	ROC-0929	Inhibitor	99.48%	Unkown
HY-15292	S107		99.89%	Unkown
HY-15705	GPR35 agonist 2		98.84%	Unkown
HY-15724A	Vercirnon sodium	Antagonist	99.13%	Unkown
HY-N0252A	Catharanthine Tartrate	Inhibitor	99.92%	Unkown
HY-N2060	Evocarpine		99.73%	Unkown
HY-P0271A	Syntide 2 TFA		99.26%	Unkown
HY-P1397A	RVD-Hpα TFA	Agonist	99.32%	Unkown
HY-P4160	PDC31	Inhibitor	99.76%	Unkown
HY-W181102	NFAT Inhibitor-2	Inhibitor	98.02%	Unkown
HY-157453	CCR4 antagonist 4	Antagonist	99.72%	Unkown
HY-W010451	1,2,4-Trihydroxybenzene	Activator	99.12%	Unkown
HY-12949A	ML204 hydrochloride	Inhibitor	99.81%	Unkown
HY-100402	CFMTI	Antagonist	≥98.0%	Unkown
HY-101428	NS-638	Inhibitor	99.84%	Unkown
HY-103277A	BIM 23042 TFA	Antagonist	99.92%	Unkown
HY-103308	TRAM-39	Inhibitor	99.66%	Unkown
HY-103442	CGP52411	Inhibitor	99.82%	Unkown
HY-106844A	(+)-EMD 57033		99.72%	Unkown
HY-107659	YM-244769 hydrochloride	Inhibitor	99.02%	Unkown
HY-116291	4α-Phorbol 12,13-didecanoate	Agonist	≥99.0%	Unkown
HY-131040	NLRP3-IN-NBC6	Inhibitor	99.40%	Unkown
HY-136409	N-Decanoyl-L-homoserine lactone		99.43%	Unkown
HY-147301A	Resomelagon acetate	Agonist	99.75%	Unkown
HY-149662	TMDJ-035	Inhibitor	99.44%	Unkown
HY-D0110A	Fura-2 pentapotassium		≥96.0%	Unkown
HY-D1024A	Coelenterazine h hydrochloride		98.02%	Unkown
HY-E70200	Recombinant Kex2 protease		/	Unkown
HY-N0215S14	L-Phenylalanine-15N,d8	Antagonist	99.90%	Unkown
HY-N2500	Deoxypodophyllotoxin		99.87%	Unkown
HY-P1075	CALP3	Inhibitor	99.68%	Unkown
HY-P1079	ω-Agatoxin TK	Inhibitor	≥99.0%	Unkown
HY-P5189A	His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA		99.31%	Unkown
HY-W013857	Lavendustin C	Inhibitor	98.32%	Unkown
HY-W111226	Fmoc-His(3-Me)-OH	Inhibitor	/	Unkown
HY-12927	SX-517		99.88%	Unkown
HY-105118A	Zaldaride maleate	Antagonist	≥98.0%	Unkown
HY-101902	Quin-2AM		/	Unkown
HY-103317	NAADP		≥95.0%	Unkown
HY-103320B	(1R,2R)-Calhex 231 hydrochloride		99.07%	Unkown
HY-10388A	TTA-Q6(isomer)		99.84%	Unkown
HY-104056	Fura Red		/	Unkown
HY-107678	SEN12333	Agonist	98.45%	Unkown
HY-108496S	Sphingosine-1-phosphate-d7	Agonist	≥99.0%	Unkown
HY-108592	UCL 2077	Inhibitor	95.48%	Unkown
HY-11000A	CaMKP inhibitor sodium	Inhibitor	98.06%	Unkown
HY-113970A	Nebracetam hydrochloride	Agonist	≥99.0%	Unkown
HY-115745	Calmodulin antagonist-1	Antagonist	≥98.0%	Unkown
HY-117073	ITH12575	Inhibitor	99.14%	Unkown
HY-120026	KB130015	Inhibitor	98.28%	Unkown
HY-120514	JNc-440		98.04%	Unkown
HY-120528	GB-110	Agonist	/	Unkown
HY-121604	(Rac)-MEM 1003	Inhibitor	99.52%	Unkown
HY-123071	Box5	Antagonist	/	Unkown
HY-126789	DM-Nitrophen		/	Unkown
HY-136182	YM-244769 dihydrochloride	Inhibitor	99.02%	Unkown
HY-136395	Cartap	Inducer	/	Unkown
HY-13699	NBI-42902		98.65%	Unkown
HY-146268	CaMKIIα-IN-1	Inhibitor	98.41%	Unkown
HY-147384	CXL-1020		≥99.0%	Unkown
HY-15671A	GKA50 quarterhydrate	Activator	≥98.0%	Unkown
HY-A0236A	Aprindine hydrochloride	Inhibitor	/	Unkown
HY-B1221S1	Flufenamic acid-13C6		/	Unkown
HY-D0121A	INDO 1 pentapotassium		≥95.0%	Unkown
HY-N0252B	Catharanthine Sulfate	Inhibitor	/	Unkown
HY-N10772	Albanin A	Inhibitor	97.67%	Unkown
HY-N2359	Chelerythrine		/	Unkown
HY-N4267	Yangambin	Inhibitor	≥98.0%	Unkown
HY-P0271	Syntide 2		/	Unkown
HY-P1387	β-Amyloid (1-40) (rat)	Inducer	95.13%	Unkown
HY-P3811A	Autocamtide-3 acetate		99.62%	Unkown
HY-P3965	16-38-Thymosin β4 (cattle)	Activator	98.14%	Unkown
HY-P3965A	16-38-Thymosin β4 (cattle) (TFA)	Activator	98.14%	Unkown
HY-P5154A	Tamapin TFA	Antagonist	98.79%	Unkown
HY-W041308	DCOIT	Agonist	99.74%	Unkown
HY-101693	Senazodan	Inhibitor	/	Unkown
HY-12962	NMDA-IN-1	Antagonist	≥98.0%	Unkown
HY-101015	(2E)-OBAA		/	Unkown
HY-114400A	TRPV4 agonist-1	Agonist	/	Unkown
HY-103309A	ML218 hydrochloride	Inhibitor	/	Unkown
HY-125836	CCR4 antagonist 2	Antagonist	/	Unkown
HY-N1584B	Halofuginone hydrochloride		/	Unkown
HY-14656S	Diltiazem-d3 hydrochloride	Antagonist	98.46%	Unkown
HY-B0632S	Diltiazem-d6	Antagonist	/	Unkown
HY-P2471	Neurogranin (48-76), mouse	Inhibitor	/	Unkown
HY-100718	SCH00013		98.04%	Unkown
HY-100783B	Bicuculline methobromide	Antagonist	/	Unkown
HY-100934	SC-9	Activator	/	Unkown
HY-101329S	Anthracene-9-carboxylic acid-d9		/	Unkown
HY-103277	BIM 23042	Antagonist	/	Unkown
HY-103309S	ML218-d9	Inhibitor	/	Unkown
HY-103320	Calhex 231	Antagonist	/	Unkown
HY-103472	FPR-A14	Agonist	99.90%	Unkown
HY-104058	Oregon-BAPTA Green 1AM		/	Unkown
HY-106818A	Monatepil maleate		/	Unkown
HY-106837	Israpafant	Antagonist	/	Unkown
HY-107855S1	DL-Mevalonolactone-d3		/	Unkown
HY-110312	JTV-519 fumarate		/	Unkown
HY-111014	VK-II-36	Activator	99.63%	Unkown
HY-113308AS	Taurolithocholic acid-d4 sodium	Agonist	/	Unkown
HY-113308AS1	Taurolithocholic Acid-d5 sodium salt	Agonist	/	Unkown
HY-113308AS2	Taurolithocholic acid-d4-1 sodium	Agonist	/	Unkown
HY-114826	Prostaglandin E2-1-glyceryl ester	Activator	/	Unkown
HY-115493	TIQ-15	Antagonist	/	Unkown
HY-115767	(±)-1,2-Diolein	Activator	/	Unkown
HY-116330	Hyperforin		/	Unkown
HY-116429A	7(S)-Maresin 1		/	Unkown
HY-116429S	Maresin 1-d5	Inhibitor	/	Unkown
HY-117099	TMB-8	Antagonist	/	Unkown
HY-12542S	Dantrolene-13C3	Inhibitor	/	Unkown
HY-12550	GW542573X	Activator	98.79%	Unkown
HY-12596	JNJ-26489112		/	Unkown
HY-126583	Nemadipine-A	Inhibitor	/	Unkown
HY-126789A	DM-Nitrophen tertasodium		/	Unkown
HY-126821	Fluo-3		/	Unkown
HY-126821A	Fluo-3 pentaammonium		/	Unkown
HY-129088	HUP30		99.68%	Unkown
HY-129496	NP-313	Inhibitor	99.58%	Unkown
HY-129547	Fluo-3 pentapotassium		/	Unkown
HY-131001	DPNB-ABT594	Agonist	/	Unkown
HY-131012	GoSlo-SR-5-69	Activator	/	Unkown
HY-131041	Ned-K		/	Unkown
HY-131942	sFTX-3.3	Antagonist	/	Unkown
HY-132190	Hexanolamino PAF C-16	Antagonist	/	Unkown
HY-13338	Mabuterol	Agonist	/	Unkown
HY-133596	12,14-Dichlorodehydroabietic acid		/	Unkown
HY-135110	Rp-8-Br-cGMPS sodium salt	Activator	/	Unkown
HY-135433	MAPTAM		/	Unkown
HY-135478	LY393615	Inhibitor	/	Unkown
HY-136189	UK-59811 hydrochloride	Inhibitor	/	Unkown
HY-136283	DMNPE-4 AM-caged-calcium		/	Unkown
HY-136661	(-)-N6-Phenylisopropyl adenosine	Agonist	/	Unkown
HY-137790	Bicuculline methochloride	Antagonist	/	Unkown
HY-138990	GK563	Inhibitor	/	Unkown
HY-139041	Palmitoylcholine chloride		/	Unkown
HY-142050	(R)-IDHP		/	Unkown
HY-142087	Beauverolide Ja	Inhibitor	/	Unkown
HY-145196	RTICBM-189	Modulator	99.73%	Unkown
HY-145385	Coelenteramide		/	Unkown
HY-145542S	Isovalerylcarnitine-d9 chloride		/	Unkown
HY-145900	S100A2-p53-IN-1	Inhibitor	/	Unkown
HY-146232	F 13714	Agonist	/	Unkown
HY-146461	Anticancer agent 58		/	Unkown
HY-146462	Anticancer agent 59		/	Unkown
HY-14656S1	Diltiazem-(acetoxy-d3) (hydrochloride)	Antagonist	/	Unkown
HY-147005	piCRAC-1	Inhibitor	98.24%	Unkown
HY-147186	5,5'-Difluoro BAPTA		/	Unkown
HY-147377	N-Salicyloyltryptamine		96.37%	Unkown
HY-147383	NS-8	Activator	/	Unkown
HY-149483	CVN417	Antagonist	/	Unkown
HY-150039	CCG-271423	Inhibitor	/	Unkown
HY-15084B	Dizocilpine	Antagonist	/	Unkown
HY-151451	Cav 3.2 inhibitor 2	Inhibitor	/	Unkown
HY-151452	Cav 3.2 inhibitor 3	Inhibitor	/	Unkown
HY-151547	MRS4719	Antagonist	/	Unkown
HY-15293	JTV-519	Inhibitor	/	Unkown
HY-155516	KV1.3-IN-1	Inhibitor	/	Unkown
HY-156082	RyRs activator 3	Inhibitor	/	Unkown
HY-156104	CaMKIIα-PHOTAC	Degrader	/	Unkown
HY-161104	Kv2.1-IN-1	Inhibitor	/	Unkown
HY-162280	PROTAC BTK Degrader-9		/	Unkown
HY-162374	ANO61	Inhibitor	/	Unkown
HY-162375	AF299		/	Unkown
HY-16489A	Terodiline hydrochloride	Antagonist	99.78%	Unkown
HY-17404S	Cilnidipine-d7	Inhibitor	/	Unkown
HY-B0493S1	Niflumic acid-13C6	Inhibitor	/	Unkown
HY-B0596S	Taltirelin-13C,d3		/	Unkown
HY-B1221S	Flufenamic acid-d4		/	Unkown
HY-B1837A	β-Cyfluthrin	Inhibitor	99.94%	Unkown
HY-B1837AR	β-Cyfluthrin (Standard)	Inhibitor	/	Unkown
HY-D0121	INDO 1		/	Unkown
HY-D0157	ZnAF-2		/	Unkown
HY-D0861A	EGTA tetrasodium		/	Unkown
HY-D1424	Coelenterazine hcp		/	Unkown
HY-D1501	Fura PE-3 potassium		/	Unkown
HY-D1608	BODIPY FL Thapsigargin	Inhibitor	/	Unkown
HY-D1631	Calcium Green-5N AM		/	Unkown
HY-D1636	5-Nitro BAPTA		/	Unkown
HY-D1640	5',5-Difluoro BAPTA tetrapotassium		/	Unkown
HY-D1643	5,5'-Dinitro BAPTA AM		/	Unkown
HY-D1700	Mag-indo-1/AM		/	Unkown
HY-D1702	Mag-Fura-2 tetrapotassium		/	Unkown
HY-D1755	Fluo-3FF AM		/	Unkown
HY-E70197	Calpain-1 (pig)		/	Unkown
HY-N0043R	Ginsenoside Rd (Standard)	Inhibitor	/	Unkown
HY-N0081	(±)-Praeruptorin A	Inhibitor	99.31%	Unkown
HY-N0081A	(-)-Praeruptorin A	Inhibitor	/	Unkown
HY-N0742	Absinthin	Agonist	/	Unkown
HY-N10512	Gangliotetraose		/	Unkown
HY-N10754	Aschantin	Inhibitor	/	Unkown
HY-N11887	Linocinnamarin	Inhibitor	/	Unkown
HY-N1228	Soyacerebroside I		/	Unkown
HY-N3729	(-)-Denudatin B	Inhibitor	≥97.0%	Unkown
HY-N4237	Saikogenin D		98.95%	Unkown
HY-N5123	α-L-Rhamnose		/	Unkown
HY-N6688	Verruculogen	Inhibitor	97.52%	Unkown
HY-N6701	Dihydrocytochalasin B		/	Unkown
HY-N7063R	Nerol (Standard)		/	Unkown
HY-N7594	Senecionine acetate		/	Unkown
HY-N7875	Celangulin		/	Unkown
HY-N8493	Mycalolide B		/	Unkown
HY-N9404	6-Benzoylheteratisine	Inhibitor	99.66%	Unkown
HY-P1075A	CALP3 TFA	Inhibitor	/	Unkown
HY-P1076	CALP2	Antagonist	/	Unkown
HY-P1077	CALP1		/	Unkown
HY-P1080	ω-Agatoxin IVA	Inhibitor	/	Unkown
HY-P1247A	Calcineurin autoinhibitory peptide TFA	Inhibitor	/	Unkown
HY-P1250A	RFRP-3(human) TFA	Agonist	/	Unkown
HY-P1345	TLQP-21	Agonist	/	Unkown
HY-P1366A	des-Gln14-Ghrelin TFA		/	Unkown
HY-P1437A	Neuropeptide S(Mouse) TFA	Agonist	/	Unkown
HY-P1479	Calmodulin-Dependent Protein Kinase II (290-309)		/	Unkown
HY-P1805	Calmodulin Binding Peptide 1	Inhibitor	/	Unkown
HY-P1821	Myelin Basic Protein		/	Unkown
HY-P2847	Urocortin II, mouse	Inhibitor	/	Unkown
HY-P3037	Imperatoxin A	Activator	/	Unkown
HY-P3156	Syringomycin E	Inhibitor	/	Unkown
HY-P3278	Caloxin 2A1	Inhibitor	/	Unkown
HY-P3316	OSK-1	Inhibitor	/	Unkown
HY-P3811	Autocamtide-3		/	Unkown
HY-P3943	Calmodulin Dependent Protein Kinase Substrate Analog		/	Unkown
HY-P3944	Calmodulin Dependent Protein Kinase Substrate		/	Unkown
HY-P5154	Tamapin	Antagonist	/	Unkown
HY-P5422	Caloxin 3A1	Inhibitor	/	Unkown
HY-P5796	FS-2	Inhibitor	/	Unkown
HY-P5799	ω-Conotoxin MVIID	Inhibitor	/	Unkown
HY-P5802	ω-Conotoxin FVIA	Inhibitor	/	Unkown
HY-P5805	ω-Conotoxin CVIE	Inhibitor	/	Unkown
HY-P5869	Kurtoxin		/	Unkown
HY-P5870	KTX-Sp2	Inhibitor	/	Unkown
HY-P5988	N-myristoyl-RKRTLRRL	Inhibitor	/	Unkown
HY-P6008	Myoregulin		/	Unkown
HY-P6008A	Myoregulin TFA		/	Unkown
HY-P6013	wt hMLN	Inhibitor	/	Unkown
HY-Q40876	BBT	Modulator	/	Unkown
HY-RS01768	CA2 Human Pre-designed siRNA Set A		/	Unkown
HY-U00026	Semotiadil recemate fumarate		/	Unkown
HY-W019981C	Magnesium chloride hexahydrate, for cell culture	Activator	/	Unkown
HY-W040028	Cartap hydrochloride	Inducer	/	Unkown
HY-W194810	MCU-i11		/	Unkown
HY-W748509	Pipernonaline		/	Unkown
HY-W755295	Mabuterol hydrochloride	Agonist	/	Unkown
HY-101616	ABT-639 hydrochloride	Inhibitor	/	Unkown
HY-101669	TDN345	Antagonist	/	Unkown
HY-101685	Iganidipine	Antagonist	/	Unkown
HY-10341D	Fasudil mesylate		/	Unkown
HY-103544	[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P		/	Unkown
HY-113040A	(17R,18S)-Epoxyeicosatetraenoic acid	Inhibitor	/	Unkown
HY-113723	MRS2298	Antagonist	/	Unkown
HY-115231	ci-IP3/PM		/	Unkown
HY-116072	Antiarrhythmic agent-2	Inhibitor	/	Unkown
HY-130358	PDDHV	Activator	/	Unkown
HY-131948	3-Chlorodiphenylamine	Activator	/	Unkown
HY-133614	Dihydroisopimaric acid	Activator	/	Unkown
HY-138951	AY77	Agonist	/	Unkown
HY-149779	RyR2 stabilizer-1	Modulator	/	Unkown
HY-19025	CV-159	Antagonist	/	Unkown
HY-19062	SM-6586		/	Unkown
HY-B0358AS	Flunarizine-d8 dihydrochloride		/	Unkown
HY-N7364S	(E)-β-Farnesene-d6	Inhibitor	/	Unkown
HY-N7436S	Methyl propyl disulfide-d3		/	Unkown
HY-N7491A	Ent-(+)-Verticilide	Inhibitor	/	Unkown
HY-132191	Pradimicin A	Inhibitor	/	Unkown
HY-100783A	(-)-Bicuculline methochloride		/	Unkown
HY-100928	YS 035 hydrochloride		/	Unkown
HY-19805A	STO-609 acetate		/	Unkown
HY-B1726	Phenacaine		/	Unkown
HY-P0188	ω-Conotoxin MVIIC		/	Unkown
HY-P0189	ω-Conotoxin GVIA		/	Unkown
HY-U00354	CP-060	Antagonist	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Canis familiaris	CA2	VGNC	VGNC:38610
Rattus norvegicus	CA2	RGD	RGD:2240
Felis catus	CA2	VGNC	VGNC:60250
Mus musculus	CA2	MGD	MGI:88269
Macaca mulatta	CA2	VGNC	VGNC:70490
Macaca fascicularis	CA2	NCBI	NCBI:101866067
Others	CA2	NCBI